Home › Research › Tau biomarkers
Neurogranin as a Novel Biomarker in Alzheimer's Disease
Agnello L, Gambino CM, Lo Sasso B, Bivona G, Milano S, Ciaccio AM, Piccoli T, La Bella V et al.. Laboratory medicine, 2021-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background In this study, we investigated the possible role of 2 novel biomarkers of synaptic damage, namely, neurogranin and α-synuclein, in Alzheimer disease (AD). Methods The study was performed in a cohort consisting of patients with AD and those without AD, including individuals with other neurological diseases. Cerebrospinal fluid (CSF) neurogranin and α-synuclein levels were measured by sensitive enzyme-linked immunosorbent assays (ELISAs).
What this study adds
Evidence grade: Moderate
In this cohort, cerebrospinal fluid levels of neurogranin and α-synuclein were higher in patients with Alzheimer disease than in those without it, and neurogranin correlated with tau markers. Reported effect size: 84.2%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Agnello, L., Gambino, C. M., Lo Sasso, B., Bivona, G., Milano, S., Ciaccio, A. M., et al. (2021). Neurogranin as a Novel Biomarker in Alzheimer's Disease. Laboratory medicine. https://doi.org/10.1093/labmed/lmaa062
Vancouver
Agnello L, Gambino CM, Lo Sasso B, Bivona G, Milano S, Ciaccio AM, et al. Neurogranin as a Novel Biomarker in Alzheimer's Disease. Laboratory medicine. 2021. doi:10.1093/labmed/lmaa062. PMID: 32926148.
BibTeX
@article{agnello2021-32926148,
author = {Agnello, L. and Gambino, C. M. and Lo Sasso, B. and Bivona, G. and Milano, S. and Ciaccio, A. M. and Piccoli, T. and La Bella, V. and others},
title = {{Neurogranin as a Novel Biomarker in Alzheimer's Disease}},
journal = {Laboratory medicine},
year = {2021},
doi = {10.1093/labmed/lmaa062},
pmid = {32926148},
url = {https://doi.org/10.1093/labmed/lmaa062}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Methods The study was performed in a cohort consisting of patients with AD and those without AD, including individuals with other neurological diseases.
- Cerebrospinal fluid (CSF) neurogranin and α-synuclein levels were measured by sensitive enzyme-linked immunosorbent assays (ELISAs).
- Results We found significantly increased levels of CSF neurogranin and α-synuclein in patients with AD than those without AD.
- Neurogranin was correlated with total tau (tTau) and phosphorylated tau (pTau), as well as with cognitive decline, in patients with AD.
Why it matters
In this cohort, cerebrospinal fluid levels of neurogranin and α-synuclein were higher in patients with Alzheimer disease than in those without it, and neurogranin correlated with tau markers. This is a biomarker study and does not test any treatment or show that these markers can be used to prevent or cure the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Effect size84.2%
- Evidence strengthModerate
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Laboratory medicine) |
| Journal's citation record | 0 / 4 | Laboratory Medicine: journal h-index 56 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 61 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.7 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 49 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Marcello Ciaccio: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Palermo: institution h-index 473 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32926148) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.